gemcitabine has been researched along with Sezary Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, L; Cantonetti, M; Di Raimondo, C; Meconi, F; Monopoli, A; Narducci, MG; Nunzi, A; Rapisarda, V; Scala, E; Tesei, C; Vaccarini, S; Zizzari, A | 1 |
| Assaf, C; Nicolay, JP | 1 |
| Desai, N; Goff, HW; Rizvi, S; Stewart, JR; Zhu, H | 1 |
| Argnani, L; Broccoli, A; Casadei, B; Cavo, M; Morigi, A; Nanni, L; Stefoni, V; Zinzani, PL | 1 |
| Duvic, M | 1 |
| Alberti-Violetti, S; Berti, E; Corti, L; Fanoni, D; Merlo, V; Reseghetti, A; Venegoni, L; Vezzoli, P | 1 |
| Anadolu, RY; Birol, A; Erdem, C; Sanli, H; Türsen, U | 1 |
| Apisarnthanarax, N; David, CL; Duvic, M; Kurzrock, R; Talpur, R; Wen, S | 1 |
2 review(s) available for gemcitabine and Sezary Syndrome
| Article | Year |
|---|---|
[Treatment of mycosis fungoides and Sézary syndrome].
Topics: Adrenal Cortex Hormones; Bexarotene; Brentuximab Vedotin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Immunoconjugates; Interferon-alpha; Mycosis Fungoides; Neoplasm Recurrence, Local; Neoplasm Staging; Phototherapy; Polyethylene Glycols; PUVA Therapy; Sezary Syndrome; Skin Neoplasms; World Health Organization | 2017 |
Alemtuzumab is an effective third-line treatment versus single-agent gemcitabine or pralatrexate for refractory Sézary syndrome: a systematic review.
Topics: Alemtuzumab; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Deoxycytidine; Folic Acid Antagonists; Gemcitabine; Humans; Mycosis Fungoides; Retreatment; Sezary Syndrome; Skin Neoplasms | 2018 |
1 trial(s) available for gemcitabine and Sezary Syndrome
| Article | Year |
|---|---|
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Receptors, Interleukin-2; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2006 |
5 other study(ies) available for gemcitabine and Sezary Syndrome
| Article | Year |
|---|---|
Continuous low-dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study.
Topics: Deoxycytidine; Gemcitabine; Humans; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms | 2022 |
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies.
Topics: Adult; Antibodies, Monoclonal, Humanized; Deoxycytidine; Gemcitabine; Humans; Male; Sezary Syndrome; Time Factors | 2019 |
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.
Topics: Alemtuzumab; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials as Topic; Deoxycytidine; Depsipeptides; Diphtheria Toxin; Disease Progression; Doxorubicin; Electrons; Gemcitabine; Humans; Hydroxamic Acids; Immunotherapy; Incidence; Interleukin-2; Lenalidomide; Lymphoma, T-Cell; Mycosis Fungoides; Pentostatin; Photopheresis; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Retinoids; Sezary Syndrome; Stem Cell Transplantation; Thalidomide; United States; Vorinostat | 2015 |
Sézary Syndrome in a 17-Year-Old Boy: Clinicopathologic Features and Genomic Profile.
Topics: Adolescent; Antineoplastic Agents; Biopsy, Needle; Deoxycytidine; Gemcitabine; Genomics; Humans; Immunohistochemistry; Italy; Male; Prognosis; Severity of Illness Index; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2016 |
Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Child; Deoxycytidine; Female; Gemcitabine; Humans; Interferon-alpha; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Pentostatin; PUVA Therapy; Sezary Syndrome; Treatment Outcome | 2005 |